Skip to main content
FishtownFish wrapped around the rod of AsclepiusMedicine
Preventive Primary Care
How Care Works
Virtual & Home Visits
Virtual care across 40 states + house calls in Philadelphia
Concierge vs. Direct Care
Zero visit copays, zero hidden fees, relationship model
Send Medical Records
Securely upload prior labs & notes before consultation
Common Questions (FAQ)
PCP scope, insurance, labs & cancellation policies
Services
Primary Care & Acute Visits
Same-day sick visits, refills & comprehensive PCP care
Chronic & Complex Care
POTS, MCAS, Long COVID, Lyme & fatigue workups
Hormones & Endocrine
TRT, thyroid, perimenopause, menopause & PCOS
Metabolic Health & Weight
Advanced lipid testing, GLP-1s & glucose monitoring
Longevity & Prevention
Medicine 3.0 baselines, VO2 max, DEXA & prevention
All Clinical Services
Comprehensive catalogue of 36+ clinical services
Membership
Membership Details
Unlimited direct access, continuous physician care
Care Packages
The Reset & Strategic Roadmap evaluations
Billing & Payment FAQ
HSA/FSA eligibility, transparent cancellation policy
About
Meet Dr. Ash
Your Physician
GER·O·SPAN
Our Clinical Framework
Clinical Library & Articles
Evidence-based health guides reviewed by Dr. Ash
What People Say
124 patient reviews across 6 platforms
Contact Dr. Ash
Reach out with questions or book an intro
Patient PortalStart Intake
Full-Body MRI Screening
Fishtown Medicine•8 min read
4.96 (124)

Full Body MRI

The ultimate "look inside". Peace of mind vs. the incidentaloma.

Ashvin Vijayakumar MD

Medically Reviewed

Ashvin Vijayakumar MD•Updated November 15, 2026
On This Page
  • Why use MRI for whole-body screening?
  • No radiation
  • Soft-tissue contrast
  • How often do whole-body MRIs flag incidentalomas vs. cancer?
  • How do ACR guidelines separate harmless cysts from malignant tumors?
  • When does a targeted non-invasive scan spare you a needle biopsy?
  • Who is a full-body MRI for (and who should skip it)?
  • What is the strategic roadmap if your full-body MRI already flagged a spot?
  • Common Questions
  • What does a whole-body screening MRI look for?
  • How much does a full-body MRI cost?
  • What is the chance of a false alarm vs. finding cancer on a whole-body MRI?
  • What is an "incidentaloma" and how do ACR guidelines help?
  • What is ONCO-RADS on a whole-body MRI report?
  • When does a thyroid nodule on an MRI need an ultrasound or biopsy?
  • Can contrast-enhanced ultrasound (CEUS) replace a liver or kidney biopsy?
  • Can I have a full-body MRI with claustrophobia?
  • Deep Questions
  • How does diffusion-weighted imaging (DWI) detect cancer?
  • How do whole-body MRI screening centers differ?
  • Should I get a full-body MRI if I have BRCA1, Lynch, or Li-Fraumeni syndrome?
  • What is the Bosniak v2019 classification for kidney cysts?
  • How does chemical-shift MRI solve an indeterminate adrenal nodule?
  • How do Gadoxetate (Eovist) liver scans separate FNH from hepatic adenoma?
  • Why does Fishtown Medicine pair whole-body MRI discussions with Galleri?
  • ✦Key Takeaways
  • Related at Fishtown Medicine
  • Scientific References

Get a preventive doctor that knows you.

Consult Dr. Ash
TL;DR30-second take

A full-body MRI is a 60-minute scan that uses powerful magnets and diffusion-weighted imaging to look at most solid organs (brain, spine, liver, kidney, pancreas, prostate, ovaries) without radiation. It can find early cancers and brain aneurysms, but it also finds harmless quirks that drive follow-up scans and anxiety, the so-called incidentaloma tax.

TL;DR: Full-body MRI uses radiation-free diffusion-weighted imaging to look for silent internal-organ tumors and aneurysms, yet 78% to 95% of healthy scans show an abnormal finding and 15% to 32% trigger follow-up testing while finding confirmed cancer in only 1.1% to 1.6%. Keep standard cancer screenings current first, and use full-body MRI as an optional second layer only inside high-risk genetics or a guided prevention plan.

Medicine has historically been reactive. We wait for you to cough up blood before we scan your lungs. We wait for you to turn yellow before we scan your liver. By the time symptoms appear, the disease is often advanced. Whole-body MRI flips that model.

Whole-body MRI, offered at dedicated screening centers, is a proactive screen of major internal organs (brain, spine, liver, kidney, pancreas, spleen, pelvis) in about 60 minutes. The key tool is diffusion-weighted imaging (DWI), which makes tumors stand out because cancer cells are packed more tightly than healthy tissue.

The catch is that it sees almost every benign body quirk. Across large pooled meta-analyses of asymptomatic adults (Zugni et al. 2020, Ahsan et al. 2026, Martins da Fonseca et al. 2026), 78% to 95% of healthy people have an abnormal finding reported and 15% to 32% are flagged for follow-up, yet confirmed cancer is found in only 1.1% to 1.6% of scans. Even more important, no randomized trial has shown that whole-body MRI screening reduces death or illness in average-risk adults (Cochrane 2026), and medical guidelines recommend it only for high-risk genetic syndromes such as Li-Fraumeni or Lynch syndrome.

How testing works here

Dr. Ash orders this the same way he orders everything else, as part of primary care, so it is not something you can buy from us by itself. A number with nobody to read it against the rest of your picture is how most people end up with a result sitting in a portal and no idea what to do next.

What that looks like from your side is straightforward. The lab or imaging center bills you directly, at their price, with nothing added by us. Dr. Ash sends the order, reads the result next to your history and your other labs, and turns it into a plan you leave with. If there is something specific you want measured, that is a good thing to say up front.

Tell Dr. Ash what you want to find out

Whole-Body MRI Incidentalomas: The 18,043-Scan Funnel, ACR Safe Cutoffs, Thyroid & Pancreas Rules, and Non-Invasive Tie-Breakers

Why use MRI for whole-body screening?

We use MRI for whole-body screening because it has two clear advantages over CT.

No radiation

Unlike a CT scan, which is a 3D X-ray using ionizing radiation, MRI uses magnets. You can have multiple MRIs without radiation exposure or DNA damage.

Soft-tissue contrast

MRI beats CT for soft organs such as the brain, liver, pancreas, kidney, and prostate. It is much weaker than CT for air-filled or calcified structures such as the lungs and heart arteries. A whole-body MRI is not a lung cancer screen (use low-dose CT for eligible current or former smokers; never order screening chest CT in never-smokers) and not a heart plaque screen (use a coronary calcium score or CCTA).

How often do whole-body MRIs flag incidentalomas vs. cancer?

In healthy adults without symptoms, whole-body MRI flags benign cysts or nodules in almost everyone, triggers extra testing in up to a third of people, and confirms cancer in roughly 1 to 2 out of every 100 people scanned.

Study / Meta-AnalysisSample SizeAny Finding FlaggedFlagged for Further WorkupConfirmed Cancer Rate
Kwee & Kwee (JMRI 2019)5,373 adults (12 studies)Not pooled32.1% (16.0% confirmed false-positive)Not pooled
Zugni et al. (Cancer Imaging 2020)6,214 exams (12 studies)95.0% (91% of lesions benign)30.0% (cancer suspected in 1.8%)1.1%
Ahsan et al. (JGIM 2026)18,043 adults (17 studies)78.0%14.8% non-malignant actionable (20.8% had procedures)1.4%
Martins da Fonseca (Eur Radiol 2026)9,024 adultsNot pooledNot pooled1.57%
Hu et al. (ONCO-RADS) (Cancer Imaging 2024)2,064 adultsGraded 1 to 52.1% scored ONCO-RADS >= 41.2%

To stop every harmless cyst from triggering panic, radiologists created the ONCO-RADS 5-point scoring system (Petralia et al., Radiology 2021). In a validation study of 2,064 screened adults (Hu et al. 2024), cancer was present in 0.1% of Category 2 (likely benign), 5.4% of Category 3, 42.9% of Category 4, and 75.0% of Category 5 scans. Ask whether your screening center reports an ONCO-RADS score on every finding.

How do ACR guidelines separate harmless cysts from malignant tumors?

The American College of Radiology (ACR) Incidental Findings Committee publishes size and appearance cutoffs for each organ so doctors know when to stop testing and when to look closer:

  • Liver spots (ACR Liver White Paper, Gore et al. 2017): A simple fluid cyst, a classic hemangioma (blood-vessel birthmark), or focal nodular hyperplasia (FNH) is benign and needs zero follow-up at any size. In low- or average-risk adults without cirrhosis or known cancer, any smooth liver spot under 1.5 cm is benign roughly 99% of the time and needs no further workup.
  • Kidney cysts (Bosniak v2019 Classification, McGrath et al. 2025): Kidney cysts are graded from Class I to IV. Bosniak I and II cysts (simple fluid signal with a thin wall <= 2 mm) are benign (~0% cancer in Class I) and require no follow-up. Bosniak IIF cysts get calm imaging checks at 6 and 12 months, then yearly for 5 years (only ~4% ever upgrade). Bosniak III and IV cysts carry an 80% to 88% cancer rate and go to a urologist.
  • Pancreatic cysts (ACR Pancreas White Paper): A tiny incidental pancreatic cyst under 1.5 cm without warning signs enters calm MRI surveillance (yearly for 5 years if under age 65, or every 2 years if aged 65 to 79, stopping at age 80). Immediate GI referral for an endoscopic ultrasound (EUS) is reserved for worrisome features (cyst >= 3.0 cm, thickened wall, main pancreatic duct 5 to 9 mm) or high-risk stigmata (jaundice, enhancing mural nodule >= 5 mm, or main duct >= 10 mm pointing to main-duct IPMN).
  • Adrenal nodules (ACR Adrenal Guidelines): An adrenal spot under 1.0 cm needs no follow-up. Any nodule measuring <= 10 Hounsfield Units (HU) on non-contrast CT or showing a sharp fat-water signal drop on chemical-shift MRI is a benign lipid-rich adenoma (98% specificity, 0% cancer risk) and needs no further imaging. Nodules 1 to 2 cm with unclear density get a single 12-month check, whereas masses over 4.0 cm go for surgical or PET-CT evaluation.
  • Thyroid nodules (ACR 2015 White Paper vs. ACR TI-RADS 2017): Two separate rules apply. First, when a thyroid spot shows up incidentally on an MRI or CT without suspicious lymph nodes, you do not even order a thyroid ultrasound unless the nodule is >= 1.0 cm (if under age 35) or >= 1.5 cm (if age 35 or older). This rule alone prevents 35% to 46% of needless workups. Second, if you do get a dedicated thyroid ultrasound, ACR TI-RADS grades the nodule from TR1 to TR5 and recommends a needle biopsy (FNA) only at strict size cutoffs: no biopsy for TR1/TR2, >= 2.5 cm for TR3, >= 1.5 cm for TR4, and >= 1.0 cm for TR5 (see what a thyroid nodule on a scan means).

Fishtown Medicine

A 90-minute conversation with Dr. Ash. A written plan you can follow.

Start your intake

When does a targeted non-invasive scan spare you a needle biopsy?

When a whole-body MRI flags an "indeterminate" spot, the best next step is almost never a needle biopsy. A focused, single-organ scan resolves the question without needles in up to 9 out of 10 cases:

Indeterminate WB-MRI SpotNon-Invasive Tie-Breaker ScanWhat It Resolves Without BiopsyDiagnostic Accuracy
Liver spot (1 to 2 cm)Contrast-Enhanced Ultrasound (CEUS)Gas microbubbles show classic hemangioma fill-in or FNH spoke-wheel flow with zero radiation (Wu 2018).92% sensitivity / 87% specificity (drops indeterminate reads from 57% to 6%).
Liver FNH vs. AdenomaGadoxetate (Eovist) Liver MRIFNH absorbs liver-specific dye and glows bright at 20 minutes; true adenomas stay dark (Furumaya 2024).87% to 91% accuracy without a needle.
Complex Kidney CystContrast Ultrasound (CEUS)Shows whether a cyst wall has blood flow, clearing simple cysts or reclassifying Bosniak IIF (Elbanna 2021).95% to 100% sensitivity (~100% negative predictive value).
Adrenal Nodule (1 to 4 cm)Chemical-Shift Adrenal MRIDetects microscopic intracellular fat to prove a benign adrenal adenoma (Platzek 2019).94% sensitivity / 95% specificity (AUC 0.98; resolves 60% of unclear CT spots).
Prostate Spot / High PSAMultiparametric Prostate MRI (PI-RADS)PI-RADS 1 or 2 (or PI-RADS 3 with PSA density < 0.15) safely avoids prostate biopsy (Oerther 2024).91% negative predictive value for significant prostate cancer.

Note on non-cystic kidney masses: While multiparametric kidney MRI (ccLS score) spots clear-cell kidney cancer with ~93% sensitivity, MRI cannot reliably separate a benign oncocytoma from kidney cancer (Vargas 2012). Enhancing kidney masses remain one of the few places where a targeted biopsy or urology consult is still required.

Who is a full-body MRI for (and who should skip it)?

A full-body MRI is a Tier 2 add-on only after your proven Tier 1 cancer screens (colonoscopy, mammogram, HPV/Pap, PSA density, skin check, and low-dose lung CT if eligible) are complete. When we walk patients through the 78% incidentaloma math ahead of time, about 1 in 4 decides to skip the scan, while the other 3 in 4 go in with clear eyes and zero panic.

What is the strategic roadmap if your full-body MRI already flagged a spot?

Whether you want us to order a full-protocol MRI-DWI or you already paid $2,000+ for a retail scan (Prenuvo, Ezra) and are staring at a 30-page PDF, follow these four If -> Then steps:

  1. If you have not booked your Tier 1 cancer screens yet -> finish colonoscopy, mammogram, or PSA testing first: A whole-body MRI never replaces a colonoscopy (which removes precancerous polyps on the spot).
  2. If your report flags a liver cyst/hemangioma < 1.5 cm, a Bosniak I/II kidney cyst, an adrenal nodule < 1.0 cm, or a thyroid nodule < 1.5 cm (at age 35+) -> stop and do not order repeat scans: Under ACR White Paper rules, these findings are benign and need zero follow-up.
  3. If your report flags an "indeterminate" liver, kidney, or adrenal spot -> order CEUS or targeted Gadoxetate / Chemical-Shift MRI before any biopsy: Upload your PDF and DICOM image link to our intake. Dr. Ash orders the non-invasive tie-breaker scan through your insurance to spare you an unnecessary needle procedure.
  4. If a finding crosses a true high-risk threshold (ONCO-RADS 4-5, pancreatic duct >= 7 mm, Bosniak III/IV kidney mass, or TI-RADS 4-5 thyroid nodule above size cutoff) -> we quarterback the specialist referral to Penn or Jefferson: We send a concise physician note and your images directly to the right subspecialist.

A note on cost: any discount we negotiate on labs and imaging passes straight through to you, with no markup. Our affordable labs and imaging guide covers how the billing works.

✦

Key Takeaways

  1. Whole-body MRI with diffusion-weighted imaging detects soft-tissue tumors without radiation: Dedicated protocols scan from head to pelvis to flag suspicious organ lesions while avoiding ionizing radiation.
  2. False alarms affect roughly 30% of scans and drive follow-up testing: Expect benign cysts or nodules that call for calibrated follow-up imaging, blood work, or biopsy before committing to a scan.
  3. Standard cancer screenings come first: Keep colonoscopy, mammography, low-dose chest CT for eligible smokers, and cervical screening current because whole-body MRI cannot replace luminal or blood-cancer checks.
  4. Pair imaging with ApoB and metabolic prevention: Heart disease accounts for far more premature mortality than rare silent tumors, so imaging belongs inside an ongoing physician relationship with clear action thresholds.

Related at Fishtown Medicine

  • Galleri Multi-Cancer Early Detection Test: A Clinical Review - how blood-based ctDNA screening compares with whole-body MRI
  • Thyroid Nodules & Cancer Overdiagnosis - how we triage incidental thyroid findings without over-treating
  • Evidence-Based Cancer Screening - core age-appropriate screenings every adult should keep current
  • Early Cancer Detection Strategy - our CADENCE framework across standard, imaging, and blood layers
  • Lung Cancer Screening with Low-Dose CT - the proven screening scan for eligible smoking histories
  • Cleerly Coronary CT Angiography - targeted arterial imaging when cardiovascular risk is the primary concern

Scientific References

  1. Kwee RM, Kwee TC. "Whole-Body MRI for Preventive Health Screening: A Systematic Review of the Literature." Journal of Magnetic Resonance Imaging. 2019;50(5):1489-1503. PubMed
  2. Zugni F, Padhani AR, Koh DM, et al. "Whole-Body Magnetic Resonance Imaging (WB-MRI) for Cancer Screening in Asymptomatic Subjects of the General Population: Review and Recommendations." Cancer Imaging. 2020;20(1):34. PubMed
  3. Ahsan MD, Frontera N, Gurram A, et al. "The Diagnostic Yield of Whole-Body MRI as a Multi-Disease Screening Modality: A Systematic Review and Meta-Analysis." Journal of General Internal Medicine. 2026. PubMed
  4. Petralia G, Koh DM, Attariwala R, et al. "Oncologically Relevant Findings Reporting and Data System (ONCO-RADS): Guidelines for the Acquisition, Interpretation, and Reporting of Whole-Body MRI for Cancer Screening." Radiology. 2021;299(3):494-507. PubMed
  5. Hu YS, Wu CA, Lin DC, et al. "Applying ONCO-RADS to Whole-Body MRI Cancer Screening in a Retrospective Cohort of Asymptomatic Individuals." Cancer Imaging. 2024;24(1):20. PubMed
  6. Gore RM, Pickhardt PJ, Mortele KJ, et al. "Management of Incidental Liver Lesions on CT: A White Paper of the ACR Incidental Findings Committee." Journal of the American College of Radiology. 2017;14(11):1429-1437. PubMed
  7. McGrath TA, Davenport MS, Silverman SG, et al. "Bosniak Classification of Cystic Renal Masses Version 2019: Proportion of Malignancy by Class and Subclass-Systematic Review and Meta-Analysis." AJR American Journal of Roentgenology. 2025;224(3):e2432056. PubMed
  8. Gardner TB, Park WG, Allen PJ. "Diagnosis and Management of Pancreatic Cysts." Gastroenterology. 2024;166(4):578-591. PubMed
  9. Platzek I, Sieron D, Plodeck V, et al. "Chemical Shift Imaging for Evaluation of Adrenal Masses: A Systematic Review and Meta-Analysis." European Radiology. 2019;29(2):806-815. PubMed
  10. Wu M, Li L, Wang J, et al. "Contrast-Enhanced US for Characterization of Focal Liver Lesions: A Comprehensive Meta-Analysis." European Radiology. 2018;28(5):2077-2088. PubMed

Dr. Ash is a board-certified internal medicine physician at Fishtown Medicine in Philadelphia. He practices Medicine 3.0 preventive medicine so problems are found early, when they are still solvable.

Ashvin Vijayakumar MD (Dr. Ash)

Fishtown Medicine | Diagnostics

2418 E York St, Philadelphia, PA 19125·(267) 360-7927·hello@fishtownmedicine.com·HSA/FSA Eligible

Start Your Intake
Medical Disclaimer: This resource provides clinical context for educational purposes. In the world of Precision Medicine, there is no "one size fits all", the right plan must be matched to your unique lab work, physiology, and goals. Consult Dr. Ash to determine if this approach is right for you, including if you have chronic health conditions or are taking prescription medications.

Frequently Asked Questions

Common Questions

A whole-body screening MRI looks for internal organ cancers (liver, kidney, pancreas, ovary, prostate), brain aneurysms, and spine changes in about 60 minutes without radiation. It does not replace lung cancer screening (low-dose CT is required) or heart artery imaging (CCTA).
A full-body MRI costs about $1,500 to $2,500 self-pay. Insurance does not cover whole-body MRI for general screening in healthy adults, though HSA and FSA funds often apply. If a boutique scan finds a spot that needs a targeted follow-up ultrasound or MRI, we can usually order that diagnostic test through your regular insurance.
Across pooled studies of more than 18,000 healthy adults (Zugni 2020, Ahsan 2026), 78% to 95% of scans report at least one abnormal finding and 15% to 32% recommend follow-up testing, while true cancer is confirmed in 1.1% to 1.6% of people scanned.
An incidentaloma is an unexpected spot found on a scan done for another reason. The American College of Radiology (ACR) Incidental Findings White Papers give specific size and appearance rules so harmless spots (such as liver spots under 1.5 cm, Bosniak I/II kidney cysts, adrenal nodules under 1 cm, and thyroid nodules under 1.5 cm in adults 35+) can be safely left alone without biopsies.
ONCO-RADS is a 1-to-5 radiology scale created to standardize whole-body cancer screening (Petralia 2021). Scores of 1 or 2 mean normal or benign (0.1% cancer risk), 3 means indeterminate (5.4% risk), 4 means likely malignant (42.9% risk), and 5 means highly likely malignant (75% risk).
Under the ACR Incidental Thyroid Nodule White Paper, a thyroid spot seen on an MRI or CT with no abnormal lymph nodes only needs a dedicated ultrasound if it measures 1.0 cm or larger (under age 35) or 1.5 cm or larger (age 35 and up). On ultrasound, ACR TI-RADS reserves needle biopsy for nodules at or above 2.5 cm (TR3), 1.5 cm (TR4), or 1.0 cm (TR5).
Often, yes. Contrast-enhanced ultrasound (CEUS) uses harmless microbubbles that stay inside blood vessels with zero radiation and zero kidney toxicity. In meta-analyses, CEUS characterizes indeterminate liver lesions with 92% sensitivity and 87% specificity (cutting unclear diagnoses from 57% down to 6%) and rules out blood flow in complex kidney cysts with 95% to 100% sensitivity.
Yes, many imaging centers use wide-bore magnets, and we can prescribe a one-time oral medication before your appointment if tight spaces bother you.

Deep-Dive Questions

Diffusion-weighted imaging (DWI) measures the microscopic movement of water molecules inside cells. Because tumor cells pack tightly together, water movement is restricted, making tumors glow bright on DWI maps without needing IV contrast dye.
Whole-body MRI centers differ in magnet time and coil setup. A thorough MRI-DWI screening protocol takes roughly 60 minutes. Rushed 30-to-40-minute commercial scans often cut DWI slices short, which blurs small organ findings and increases indeterminate reads.
If you carry a high-risk germline mutation (such as TP53 / Li-Fraumeni, where annual whole-body MRI is NCCN guideline-backed, or Lynch / BRCA), your imaging schedule should be built alongside a genetics specialist and matched to the specific organs at risk.
The 2019 Bosniak update added formal MRI criteria for kidney cysts (McGrath 2025). Classes I and II are benign fluid cysts that need no follow-up. Class IIF has slightly thicker walls or septa and gets periodic MRI checks (only ~4% progress to cancer over 4+ years). Classes III and IV show thick enhancing walls or nodules (~80% to 88% malignancy) and require urology referral.
Roughly 70% of benign adrenal adenomas contain microscopic intracellular fat. Chemical-shift MRI compares in-phase and opposed-phase signals: if the nodule drops signal homogeneously on the opposed-phase image, it confirms a benign adenoma with 94% sensitivity and 95% specificity (Platzek 2019), sparing the patient a radiation-heavy washout CT or biopsy.
Focal nodular hyperplasia (FNH) is a harmless cluster of liver cells with working OATP1B3 transporters that soak up hepatobiliary contrast (gadoxetate) and glow bright on the 20-minute delayed MRI phase. Most hepatic adenomas lack those transporters and look dark on the 20-minute phase, solving 87% to 91% of unclear liver spots without a needle (Furumaya 2024).
Both are optional Tier 2 tools with opposite strengths and blind spots: whole-body MRI has high sensitivity for structural organ masses but a 30% to 78% incidental finding rate, whereas the Galleri cell-free DNA blood test has a 99.5% specificity (only a 0.5% false-positive rate) but misses many Stage I tumors.

Ready when you are

Start your intake

The chat is our AI assistant, answering from our published guides. To talk it through with Dr. Ash himself, start with the intake.

Related Intelligence

Early Cancer Detection and Whole Body MRI Philadelphia | Medicine 3.0

Early Cancer Detection and Whole Body MRI Philadelphia | Medicine 3.0

Go beyond standard cancer screening. A Philadelphia primary care practice using liquid biopsies and whole-body MRI to find disease earlier.

Read Deep Dive
Preventive Cardiology Philadelphia | ApoB & Lp(a) Testing

Preventive Cardiology Philadelphia | ApoB & Lp(a) Testing

Standard cholesterol panels miss most heart attacks. See how a Philadelphia preventive cardiology approach uses ApoB, Lp(a), and modern imaging to catch risk early.

Read Deep Dive
Medicine 3.0 Philadelphia | The Systems-Biology Model of Longevity

Medicine 3.0 Philadelphia | The Systems-Biology Model of Longevity

What Medicine 3.0 means and how a Philadelphia primary care practice uses it to extend healthspan rather than lifespan alone.

Read Deep Dive

New patients

Talk it through with Dr. Ash.

If anything you read here raised a question, share it in your own words. Dr. Ash reads every intake personally, and you can text or email us anytime.

HSA/FSA eligible
No initiation or cancellation fees
No copays
Tell Dr. Ash what’s going on →
FishtownFish wrapped around the rod of AsclepiusMedicine
Preventive Primary Care
2418 E York St, Philadelphia, PA 19125(267) 360-7927Primary care in PhiladelphiaHome visits in Greater PhiladelphiaPricing & MembershipGER·O·SPAN: our clinical frameworkDigital Health LiteracyClinical Evidence & Research

Serving Fishtown · Northern Liberties · East Kensington · Olde Richmond · Port Richmond · Old City · Callowhill · Poplar · Center City · Center City West · Art Museum · Bella Vista · Chestnut Hill · Fairmount · Fitler Square · Graduate Hospital · Logan Square · Manayunk · Queen Village · Rittenhouse · Roxborough · Society Hill · Southwark · Bryn Mawr, PA · Gladwyne, PA · Villanova, PA · Wayne, PA · Cherry Hill, NJ · Haddonfield, NJ · Medford, NJ · Moorestown, NJ · Voorhees, NJ

Explore by topic

Women’s Health
  • Perimenopause
  • Menopause 3.0
  • PCOS
  • Fertility
Men’s Health
  • Testosterone (TRT)
  • Sleep Apnea & Low T
  • Andropause
  • Low Libido
Metabolic
  • Medical Weight Loss
  • Ozempic vs Metformin
  • Fasting Protocols
  • Visceral Fat
Cardiovascular
  • apoB & Heart Health
  • apoB vs LDL
  • Lp(a) Cholesterol
  • ED & Heart Risk
Longevity + Performance
  • Healthspan vs Lifespan
  • Biological Age
  • VO2 Max
  • Zone 2 Training
Supplements
  • Magnesium
  • Creatine
  • Omega-3
  • Foundational Stack
  • Supplement Guides
Care in Philadelphia +
Direct Primary Care in Philadelphia, PAConcierge Medicine in Philadelphia, PAConcierge vs DPC in Philadelphia, PALongevity Medicine in Philadelphia, PAPreventive Care in Philadelphia, PAExecutive Physical in Philadelphia, PAAnnual Physical in Philadelphia, PAHealthspan Optimization in Philadelphia, PAFunctional Medicine in Philadelphia, PASame-Day Sick Visits in Philadelphia, PATestosterone Replacement Therapy in Philadelphia, PAPerimenopause Care in Philadelphia, PAMenopause Care in Philadelphia, PAThyroid Treatment in Philadelphia, PAPCOS Care in Philadelphia, PAGLP-1 Weight Loss in Philadelphia, PAMetabolic Health in Philadelphia, PAHormone Optimization in Philadelphia, PAAdvanced Lipid Testing in Philadelphia, PAVO2 Max Testing in Philadelphia, PADEXA Scan in Philadelphia, PACGM in Philadelphia, PALong COVID Care in Philadelphia, PAChronic Fatigue Treatment in Philadelphia, PAPOTS Treatment in Philadelphia, PAMCAS Treatment in Philadelphia, PALyme Disease Care in Philadelphia, PABrain Fog Treatment in Philadelphia, PASleep Disorders Treatment in Philadelphia, PAStrep Throat Treatment in Philadelphia, PAUTI Treatment in Philadelphia, PASinus Infection Treatment in Philadelphia, PASTI Testing in Philadelphia, PATravel Medicine in Philadelphia, PAPre-Op Clearance in Philadelphia, PASports Club Medicine in Philadelphia, PA

Made it this far? You’re already most of the way there. let’s get started → Dr. Ash reads every word personally.

Content is for educational purposes only and does not constitute medical advice.

TermsPrivacyScope of PracticeClinical IndependenceCare NetworkResearch & Monographs